📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. (2025)

First Author: EMPA-KIDNEY Collaborative Group

Attributed to: Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2409183

PubMed Identifier: 39453837

Publication URI: http://europepmc.org/abstract/MED/39453837

Type: Journal Article/Review

Volume: 392

Parent Publication: The New England journal of medicine

Issue: 8

ISSN: 0028-4793